4starter
BGBIO.OL OSL
BerGenBio ASA

Single answer

Is BerGenBio ASA (BGBIO.OL) a buy or sell?

Review the recorded signal, check how recent the data is, and weigh the evidence before deciding.

Signal recorded: Not available Sector Healthcare Industry Biotechnology How the analysis works
Verdict Signal unavailable

A verified signal is not available for this stock. Missing data is not a Hold recommendation. Review the available company and price information and check back for an updated signal.

Price move

The stock is down 24.64 in the current move, which weighs on near-term confidence.

Volume pressure

Trading volume is only 0.44x normal pace versus an average session of 189,434.

Decision checklist
The setup is mixed and worth monitoring.
Watch
Signal conviction

There is not enough score context yet to rate conviction cleanly.

Watch
Market confirmation

The stock has already moved 24.64 in the current move, so the hold view may not stay neutral for long.

Against
Support check

Trading is only 0.44x normal volume, so follow-through still looks thin.

Decision snapshot

Everything you need to act fast, in one glance.

4starter signal
Signal unavailable
Not available

Latest recorded technical signal; check its date and supporting evidence.

Analyst target gap
Member context

Create a free account to follow this stock with watchlist actions, alerts, and richer live context.

Volume vs average
56.07%
under average

83,209 vs 189,434 average (0.44x normal).

Create your free account

Track BGBIO.OL with a free account

Create a free account to follow this stock with live context, target view, watchlist actions, and alerts when the signal changes.

Create free account Sign in

What changed in the current view

Use these shifts to understand why the page leans buy, hold, or sell right now.

Price move

The stock is down 24.64 in the current move, which weighs on near-term confidence.

Volume pressure

Trading volume is only 0.44x normal pace versus an average session of 189,434.

Risk watch

These are the conditions most likely to weaken the current stock view.

Review risks beyond the available data

The available indicators do not provide a complete risk assessment. Check company news, earnings dates and liquidity before deciding.

What to monitor next

These are the next checks that matter if you want to follow the stock instead of reading it once.

Watch whether the signal holds

The current signal was refreshed recently. A stable follow-through matters more than one isolated print.

Watch whether volume normalizes

Current trading is running at 0.44x normal pace. If that fades quickly, conviction can fade with it.

Signal context

Compare public sector context, then sign in for completed-signal reliability and history.

Signal reliability on this ticker

How completed signals on this stock have behaved historically.

Member context

Create a free account to see how completed signals on this ticker have performed and whether the pattern deserves more trust.

Sector pulse

See how the latest signal on this stock compares with other names in the same sector.

Peer signals 1
Dominant tone Sell
Dominant share 100.00%

Across mapped peers for Healthcare, the latest signals currently break down to 0 buy, 0 hold, and 1 sell.

Photocure ASA
PHO.OL • OSL
Sell

Recent signal history

See how the last completed signals on this ticker actually played out after they fired.

Member context

Create a free account to review the last completed signal outcomes on this ticker instead of relying on the current view alone.

Create your free account Create a free account to follow this stock with watchlist actions, alerts, and richer live context.
Create free account Sign in

What is the conclusion?

The latest recorded technical signal:

Signal unavailable

Do analysts agree?

We compare consensus targets with today's price.

Member context

Create a free account to follow analyst and signal changes on this stock over time.

Create free account

Supporting context

Use these cards to validate the signal, understand the business, and spot risks around the current verdict.

Company snapshot

A quick overview of the business and its public profile.

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II clinical trial program focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as COVID-19. In addition, it is developing tilvestamab, an anti-AXL antibody that is in Phase Ib clinical trial. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Website: www.bergenbio.com

How to use this page

Start with the verdict and reason above. Use the method and analyst sections below to pressure-test the answer, not replace it.

Why this answer

The verdict displays the latest technical signal recorded for this ticker. Price history, trend, volume and analyst information provide separate context; they are not all inputs to a single verified forecast. See our methodology for data sources and limitations.

Check the signal date. Compare the price trend and volume with recent company news. Set a risk limit and identify what would make you change your decision. A signal can help organize the evidence, but it cannot remove uncertainty.

How the analysis works

Analyst consensus

How Wall Street targets compare to today's price.

Member context

Create a free account to keep tracking stocks, follow signal changes, and use watchlist alerts.

Create free account

BGBIO.OL

FAQ

How the analysis works

A verified signal is not available for this stock. Missing data is not a Hold recommendation. Review the available company and price information and check back for an updated signal.

A verified signal is not available for this stock. Missing data is not a Hold recommendation. Review the available company and price information and check back for an updated signal.

Each data source can update at a different time. The public summary uses cached market data; member features may request newer quotes and analyst data. Use the signal date and price date shown on the page, rather than assuming every figure is live.

The verdict displays the latest technical signal recorded for this ticker. Price history, trend, volume and analyst information provide separate context; they are not all inputs to a single verified forecast. See our methodology for data sources and limitations.